Breaking News Instant updates and real-time market news.

MAR

Marriott

$101.24 /

-3.17 (-3.04%)

13:35
09/18/20
09/18
13:35
09/18/20
13:35

Marriott put volume heavy and directionally bearish

Bearish flow noted in Marriott with 11,242 puts trading, or 3x expected. Most active are Oct-20 90 puts and Oct-20 95 puts, with total volume in those strikes near 6,700 contracts. The Put/Call Ratio is 2.62, while ATM IV is up over 2 points on the day. Earnings are expected on November 9th.

MAR Marriott
$101.24 /

-3.17 (-3.04%)

08/17/20 Barclays
Marriott price target raised to $108 from $105 at Barclays
08/14/20
Fly Intel: Top five analyst upgrades
08/14/20 Jefferies
Marriott upgraded to Buy from Hold at Jefferies
08/11/20 BMO Capital
Marriott price target raised to $83 from $78 at BMO Capital

TODAY'S FREE FLY STORIES

Earnings
Rent-A-Center reports Q3 EPS $1.04, consensus 96c » 16:26
10/28/20
10/28
16:26
10/28/20
16:26
RCII

Rent-A-Center

$32.02 /

-0.35 (-1.08%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCII Rent-A-Center
$32.02 /

-0.35 (-1.08%)

RCII Rent-A-Center
$32.02 /

-0.35 (-1.08%)

10/12/20 Loop Capital
Rent-A-Center downgraded to Hold from Buy at Loop Capital
09/22/20 Loop Capital
Rent-A-Center Q3 guidance impressive amid receding tailwinds, says Loop Capital
08/07/20 Loop Capital
Rent-A-Center price target raised to $34 from $29 at Loop Capital
07/01/20
Fly Intel: Top five analyst downgrades
RCII Rent-A-Center
$32.02 /

-0.35 (-1.08%)

RCII Rent-A-Center
$32.02 /

-0.35 (-1.08%)

RCII Rent-A-Center
$32.02 /

-0.35 (-1.08%)

Earnings
Annaly Capital reports Q3 core EPS 32c, consensus 26c » 16:26
10/28/20
10/28
16:26
10/28/20
16:26
NLY

Annaly Capital

$6.99 /

-0.125 (-1.76%)

Reports book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLY Annaly Capital
$6.99 /

-0.125 (-1.76%)

NLY Annaly Capital
$6.99 /

-0.125 (-1.76%)

07/24/20 Deutsche Bank
Deutsche Bank upgrades Annaly Capital to Buy, sees 20% total return
07/24/20 Deutsche Bank
Annaly Capital upgraded to Buy from Hold at Deutsche Bank
07/07/20 Piper Sandler
Annaly Capital initiated with an Overweight at Piper Sandler
04/30/20 JMP Securities
Annaly Capital upgraded to Outperform from Market Perform at JMP Securities
NLY Annaly Capital
$6.99 /

-0.125 (-1.76%)

NLY Annaly Capital
$6.99 /

-0.125 (-1.76%)

Earnings
Selective Insurance reports Q3 adjusted EPS $1.06, consensus $1.07 » 16:26
10/28/20
10/28
16:26
10/28/20
16:26
SIGI

Selective Insurance

$52.74 /

-1.24 (-2.30%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIGI Selective Insurance
$52.74 /

-1.24 (-2.30%)

SIGI Selective Insurance
$52.74 /

-1.24 (-2.30%)

05/14/20 Credit Suisse
Selective Insurance upgraded to Outperform from Underperform at Credit Suisse
03/09/20 JMP Securities
Selective Insurance upgraded to Outperform at JMP Securities
SIGI Selective Insurance
$52.74 /

-1.24 (-2.30%)

Hot Stocks
Cognex raises quarterly dividend by 9% to 6c per share » 16:26
10/28/20
10/28
16:26
10/28/20
16:26
CGNX

Cognex

$65.23 /

-1.59 (-2.38%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGNX Cognex
$65.23 /

-1.59 (-2.38%)

CGNX Cognex
$65.23 /

-1.59 (-2.38%)

10/16/20 Stephens
Cognex initiated with an Overweight at Stephens
09/04/20 Daiwa
Cognex downgraded to Neutral from Outperform at Daiwa
08/25/20 Wolfe Research
Cognex initiated with an Underperform at Wolfe Research
07/28/20 Northcoast
Survey points to soft end of quarter for Cognex, says Northcoast
CGNX Cognex
$65.23 /

-1.59 (-2.38%)

CGNX Cognex
$65.23 /

-1.59 (-2.38%)

Earnings
Echo Global sees Q4 revenue $675M-$725M, consensus $586.05M  16:26
10/28/20
10/28
16:26
10/28/20
16:26
ECHO

Echo Global

$25.32 /

-1.68 (-6.22%)

 
ShowHide Related Items >><<
ECHO Echo Global
$25.32 /

-1.68 (-6.22%)

ECHO Echo Global
$25.32 /

-1.68 (-6.22%)

07/24/20 Barrington
Echo Global price target raised to $30 from $22 at Barrington
07/17/20 SunTrust
SunTrust raises price targets in select Trucking/Logistics names
05/21/20 Stephens
Echo Global upgraded to Overweight on positive brokerage trends at Stephens
05/21/20 Stephens
Echo Global upgraded to Overweight from Equal Weight at Stephens
ECHO Echo Global
$25.32 /

-1.68 (-6.22%)

Earnings
James River Group reports Q3 adj. EPS 56c, consensus 46c » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
JRVR

James River Group

$52.31 /

-0.43 (-0.82%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JRVR James River Group
$52.31 /

-0.43 (-0.82%)

09/18/20 Compass Point
Compass Point starts James River Group at Neutral amid transition
09/17/20 Compass Point
James River Group initiated with a Neutral at Compass Point
07/09/20 B. Riley FBR
James River Group price target raised to $55 from $50 at B. Riley FBR
06/15/20 B. Riley FBR
B. Riley FBR upgrades James River to Buy, sees takeout potential
JRVR James River Group
$52.31 /

-0.43 (-0.82%)

Earnings
Pilgrim's Pride reports Q3 EPS 66c, consensus 35c » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
PPC

Pilgrim's Pride

$15.76 /

-0.44 (-2.72%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPC Pilgrim's Pride
$15.76 /

-0.44 (-2.72%)

PPC Pilgrim's Pride
$15.76 /

-0.44 (-2.72%)

06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 BMO Capital
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
06/29/20 BMO Capital
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
06/29/20 Barclays
Pilgrim's Pride downgraded to Equal Weight from Overweight at Barclays
PPC Pilgrim's Pride
$15.76 /

-0.44 (-2.72%)

PPC Pilgrim's Pride
$15.76 /

-0.44 (-2.72%)

PPC Pilgrim's Pride
$15.76 /

-0.44 (-2.72%)

Earnings
Echo Global reports Q3 non-GAAP EPS 40c, consensus 29c » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
ECHO

Echo Global

$25.32 /

-1.68 (-6.22%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECHO Echo Global
$25.32 /

-1.68 (-6.22%)

ECHO Echo Global
$25.32 /

-1.68 (-6.22%)

07/24/20 Barrington
Echo Global price target raised to $30 from $22 at Barrington
07/17/20 SunTrust
SunTrust raises price targets in select Trucking/Logistics names
05/21/20 Stephens
Echo Global upgraded to Overweight on positive brokerage trends at Stephens
05/21/20 Stephens
Echo Global upgraded to Overweight from Equal Weight at Stephens
ECHO Echo Global
$25.32 /

-1.68 (-6.22%)

Earnings
Howard Bancorp reports Q3 adjusted EPS 25c, consensus 19c » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
HBMD

Howard Bancorp

$9.58 /

-0.23 (-2.34%)

Mary Ann Scully, Chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBMD Howard Bancorp
$9.58 /

-0.23 (-2.34%)

01/06/20 Stephens
Howard Bancorp resumed with an Equal Weight at Stephens
HBMD Howard Bancorp
$9.58 /

-0.23 (-2.34%)

Earnings
MobileIron reports Q3 EPS (7c), consensus (4c) » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
MOBL

MobileIron

$7.02 /

+ (+0.00%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOBL MobileIron
$7.02 /

+ (+0.00%)

MOBL MobileIron
$7.02 /

+ (+0.00%)

10/16/20 Roth Capital
MobileIron downgraded to Neutral at Roth Capital on pending acquisition
10/16/20 Roth Capital
MobileIron downgraded to Neutral from Buy at Roth Capital
09/29/20 Northland
Thoma Bravo unlikely to step up to pay more for MobileIron, says Northland
09/25/20 Raymond James
MobileIron deal could make sense at $7.50-$9.00 per share, says Raymond James
MOBL MobileIron
$7.02 /

+ (+0.00%)

MOBL MobileIron
$7.02 /

+ (+0.00%)

MOBL MobileIron
$7.02 /

+ (+0.00%)

Earnings
Invitation Homes reports Q3 core FFO 30c, consensus 31c » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
INVH

Invitation Homes

$27.33 /

-0.72 (-2.57%)

Reports Q3 revenue $459M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INVH Invitation Homes
$27.33 /

-0.72 (-2.57%)

INVH Invitation Homes
$27.33 /

-0.72 (-2.57%)

10/08/20 Mizuho
Invitation Homes price target raised to $31 from $30 at Mizuho
10/01/20 Berenberg
Invitation Homes initiated with a Buy at Berenberg
09/24/20 Zelman
Invitation Homes upgraded to Buy from Hold at Zelman
09/09/20 Goldman Sachs
Invitation Homes upgraded to Buy from Sell at Goldman Sachs
INVH Invitation Homes
$27.33 /

-0.72 (-2.57%)

  • 02
    Jun
  • 21
    Nov
INVH Invitation Homes
$27.33 /

-0.72 (-2.57%)

INVH Invitation Homes
$27.33 /

-0.72 (-2.57%)

Conference/Events
Castle Biosciences to host conference call » 16:25
10/28/20
10/28
16:25
10/28/20
16:25
CSTL

Castle Biosciences

$49.31 /

-2.1 (-4.08%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$49.31 /

-2.1 (-4.08%)

CSTL Castle Biosciences
$49.31 /

-2.1 (-4.08%)

10/13/20 Canaccord
Castle Biosciences price target raised to $61 from $52 at Canaccord
09/25/20 SVB Leerink
Castle Biosciences price target raised to $57 from $50 at SVB Leerink
09/03/20 Canaccord
Castle Biosciences price target raised to $52 from $47 at Canaccord
08/11/20 SVB Leerink
Castle Biosciences price target raised to $50 from $45 at SVB Leerink
CSTL Castle Biosciences
$49.31 /

-2.1 (-4.08%)

  • 25
    Jun
CSTL Castle Biosciences
$49.31 /

-2.1 (-4.08%)

CSTL Castle Biosciences
$49.31 /

-2.1 (-4.08%)

Earnings
QuinStreet sees Q2 revenue $118M-$122M, consensus $117.77M » 16:24
10/28/20
10/28
16:24
10/28/20
16:24
QNST

QuinStreet

$15.61 /

-0.6 (-3.70%)

"Looking ahead to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QNST QuinStreet
$15.61 /

-0.6 (-3.70%)

QNST QuinStreet
$15.61 /

-0.6 (-3.70%)

10/20/20 Lake Street
QuinStreet price target raised to $20 from $14 at Lake Street
09/03/20 Barrington
QuinStreet upgraded to Outperform from Market Perform at Barrington
05/07/20 Lake Street
QuinStreet price target lowered to $11 from $19 at Lake Street
04/16/20 Barrington
QuinStreet downgraded to Market Perform from Outperform at Barrington
QNST QuinStreet
$15.61 /

-0.6 (-3.70%)

Earnings
Teladoc reports Q3 EPS (43c), consensus (32c) » 16:24
10/28/20
10/28
16:24
10/28/20
16:24
TDOC

Teladoc

$227.00 /

+4.42 (+1.99%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

05:02 Today Piper Sandler
Livongo Health downgraded to Neutral from Overweight at Piper Sandler
05:00 Today Piper Sandler
Teladoc price target raised to $305 from $232 at Piper Sandler
10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

Earnings
Axis Capital reports Q3 operating EPS (77c), consensus (48c) » 16:24
10/28/20
10/28
16:24
10/28/20
16:24
AXS

Axis Capital

$44.62 /

-0.885 (-1.95%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXS Axis Capital
$44.62 /

-0.885 (-1.95%)

AXS Axis Capital
$44.62 /

-0.885 (-1.95%)

04/01/20 Wells Fargo
Axis Capital price target lowered to $43 from $60 at Wells Fargo
01/06/20 Wells Fargo
Axis Capital downgraded to Underweight at Wells Fargo
01/06/20 Wells Fargo
Axis Capital downgraded to Underweight from Equal Weight at Wells Fargo
AXS Axis Capital
$44.62 /

-0.885 (-1.95%)

AXS Axis Capital
$44.62 /

-0.885 (-1.95%)

Earnings
QuinStreet reports Q1 adjusted EPS 16c, consensus 9c » 16:24
10/28/20
10/28
16:24
10/28/20
16:24
QNST

QuinStreet

$15.61 /

-0.6 (-3.70%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QNST QuinStreet
$15.61 /

-0.6 (-3.70%)

QNST QuinStreet
$15.61 /

-0.6 (-3.70%)

10/20/20 Lake Street
QuinStreet price target raised to $20 from $14 at Lake Street
09/03/20 Barrington
QuinStreet upgraded to Outperform from Market Perform at Barrington
05/07/20 Lake Street
QuinStreet price target lowered to $11 from $19 at Lake Street
04/16/20 Barrington
QuinStreet downgraded to Market Perform from Outperform at Barrington
QNST QuinStreet
$15.61 /

-0.6 (-3.70%)

Earnings
Impinj sees Q4 adjusted EPS (40c)-(34c), consensus (25c) » 16:23
10/28/20
10/28
16:23
10/28/20
16:23
PI

Impinj

$27.85 /

-1.5 (-5.11%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PI Impinj
$27.85 /

-1.5 (-5.11%)

PI Impinj
$27.85 /

-1.5 (-5.11%)

07/10/20 Needham
Impinj price target raised to $34 from $25 at Needham
07/10/20 Piper Sandler
Impinj price target raised to $35 from $29 at Piper Sandler
04/28/20 Needham
Impinj price target raised to $25 from $19 at Needham
04/28/20 Canaccord
Impinj price target lowered to $35 from $40 at Canaccord
PI Impinj
$27.85 /

-1.5 (-5.11%)

PI Impinj
$27.85 /

-1.5 (-5.11%)

Earnings
Vanda Pharmaceuticals sees FY20 revenue $240M-$260M, consensus $251.05M » 16:23
10/28/20
10/28
16:23
10/28/20
16:23
VNDA

Vanda Pharmaceuticals

$10.08 /

-0.53 (-5.00%)

Expects year-end 2020…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

06/09/20 Citi
Vanda downgraded to Neutral on FDA dispute at Citi
06/09/20 Citi
Vanda Pharmaceuticals downgraded to Neutral from Buy at Citi
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Oppenheimer
Vanda Pharmaceuticals downgraded to Underperform at Oppenheimer on Hetlioz risks
VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

Earnings
Donegal Group Inc. reports Q3 EPS 29c, consensus 24c » 16:23
10/28/20
10/28
16:23
10/28/20
16:23
DGICA

Donegal Group

$14.05 /

-0.46 (-3.17%)

, DGICB

Donegal Group Inc.

$11.99 /

-0.49 (-3.93%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DGICA Donegal Group
$14.05 /

-0.46 (-3.17%)

02/25/20 Boenning & Scattergood
Donegal Group upgraded to Outperform from Neutral at Boenning & Scattergood
DGICB Donegal Group Inc.
$11.99 /

-0.49 (-3.93%)

Earnings
Conmed not providing FY20 guidance » 16:23
10/28/20
10/28
16:23
10/28/20
16:23
CNMD

Conmed

$79.41 /

-1.57 (-1.94%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNMD Conmed
$79.41 /

-1.57 (-1.94%)

CNMD Conmed
$79.41 /

-1.57 (-1.94%)

09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
CNMD Conmed
$79.41 /

-1.57 (-1.94%)

Earnings
Impinj reports Q3 adjusted EPS (29c), consensus (32c) » 16:23
10/28/20
10/28
16:23
10/28/20
16:23
PI

Impinj

$27.85 /

-1.5 (-5.11%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PI Impinj
$27.85 /

-1.5 (-5.11%)

PI Impinj
$27.85 /

-1.5 (-5.11%)

07/10/20 Needham
Impinj price target raised to $34 from $25 at Needham
07/10/20 Piper Sandler
Impinj price target raised to $35 from $29 at Piper Sandler
04/28/20 Needham
Impinj price target raised to $25 from $19 at Needham
04/28/20 Canaccord
Impinj price target lowered to $35 from $40 at Canaccord
PI Impinj
$27.85 /

-1.5 (-5.11%)

PI Impinj
$27.85 /

-1.5 (-5.11%)

Earnings
Conmed reports Q3 EPS 88c, consensus 23c » 16:23
10/28/20
10/28
16:23
10/28/20
16:23
CNMD

Conmed

$79.41 /

-1.57 (-1.94%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNMD Conmed
$79.41 /

-1.57 (-1.94%)

CNMD Conmed
$79.41 /

-1.57 (-1.94%)

09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
CNMD Conmed
$79.41 /

-1.57 (-1.94%)

Hot Stocks
Encompass Health sees Q4 adjusted EBITDA $225M-$240M  16:23
10/28/20
10/28
16:23
10/28/20
16:23
EHC

Encompass Health

$63.82 /

-1.18 (-1.82%)

 
ShowHide Related Items >><<
EHC Encompass Health
$63.82 /

-1.18 (-1.82%)

EHC Encompass Health
$63.82 /

-1.18 (-1.82%)

09/09/20 Mizuho
Encompass Health valuation 'dislocated' due to pandemic, says Mizuho
05/29/20 Mizuho
Encompass Health price target lowered to $87 from $90 at Mizuho
04/20/20 BMO Capital
Encompass Health price target raised to $83 from $66 at BMO Capital
03/06/20 Deutsche Bank
Encompass Health price target raised to $83 from $73 at Deutsche Bank
EHC Encompass Health
$63.82 /

-1.18 (-1.82%)

Earnings
Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c » 16:22
10/28/20
10/28
16:22
10/28/20
16:22
EHC

Encompass Health

$63.82 /

-1.18 (-1.82%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EHC Encompass Health
$63.82 /

-1.18 (-1.82%)

EHC Encompass Health
$63.82 /

-1.18 (-1.82%)

09/09/20 Mizuho
Encompass Health valuation 'dislocated' due to pandemic, says Mizuho
05/29/20 Mizuho
Encompass Health price target lowered to $87 from $90 at Mizuho
04/20/20 BMO Capital
Encompass Health price target raised to $83 from $66 at BMO Capital
03/06/20 Deutsche Bank
Encompass Health price target raised to $83 from $73 at Deutsche Bank
EHC Encompass Health
$63.82 /

-1.18 (-1.82%)

Earnings
Vanda Pharmaceuticals reports Q3 EPS 11c, consensus 9c » 16:22
10/28/20
10/28
16:22
10/28/20
16:22
VNDA

Vanda Pharmaceuticals

$10.08 /

-0.53 (-5.00%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

06/09/20 Citi
Vanda downgraded to Neutral on FDA dispute at Citi
06/09/20 Citi
Vanda Pharmaceuticals downgraded to Neutral from Buy at Citi
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Oppenheimer
Vanda Pharmaceuticals downgraded to Underperform at Oppenheimer on Hetlioz risks
VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.